| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000025476 |
| Receipt No. | R000029317 |
| Official scientific title of the study | Improvement effect of test food on Vascular endothelial function |
| Date of disclosure of the study information | 2017/01/26 |
| Last modified on | 2017/04/27 (Ver. 8) |
| Basic information | ||
| Official scientific title of the study | Improvement effect of test food on Vascular endothelial function | |
| Title of the study (Brief title) | Improvement effect of test food on Vascular endothelial function | |
| Region |
|
|
| Condition | ||
| Condition | Healthy volunteer | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | This study aims to evaluate improvement effects on Vascular endothelial function |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | FMD after eight -weeks ingestion of test food |
| Key secondary outcomes | |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Double blind -all involved are blinded |
| Control | Placebo |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 3 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | Ingestion of test food (low dose) consecutively for eight weeks | |
| Interventions/Control_2 | Ingestion of control food (high dose) for eight weeks | |
| Interventions/Control_3 | Ingestion of control food for eight weeks | |
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1)50 to 65 years at the time of informed consent and healthy male and female | |||
| Key exclusion criteria | 1)Subjects who previous or present serious disease such digestive, liver, kidney, circulatory, blood, endocrine disorder
2)Subjects who are taking medicine or being treated by a doctor 3)Subjects who are intend to undergo treatment or medication by a doctor during the test period 4)Subjects who plan to take specified healthy food, functionality food, supplement in the test period 5)Subjects who perform high exercise intensity with fatigue the next day or Manual labor 6)Night worker 7)Subjects who take excessive alcohol 8)Subjects who smoke present or have smoked within the last one year prior to the current study 9)Subjects who may cause allergic to urewa 10)Subjects who may cause symptoms of diarrhea against sugar alcohols 11)Women who are not over a year since the last menstruation 12)Women who are pregnant or may be pregnant 13)Women who are breast-feeding 14)Subjects who are planning to participate in other clinical study 15)Subjects who are judged as unsuitable for the study by the person in charge for other reason |
|||
| Target sample size | 90 | |||
| Research contact person | |
| Name of lead principal investigator | Kei Yui |
| Organization | FANCL Corporation |
| Division name | Research Institute |
| Address | Kamishinano 12-13, Totsuka-ku, Yokohama, Kanagawa,244-0806 |
| TEL | 045-820-3522 |
| tsubokawa_masaya@fancl.co.jp | |
| Public contact | |
| Name of contact person | Masaya Tsubokawa |
| Organization | FANCL Corporation |
| Division name | Research Institute |
| Address | Kamishinano 12-13, Totsuka-ku, Yokohama, Kanagawa,244-0806 |
| TEL | 045-820-3659 |
| Homepage URL | |
| tsubokawa_masaya@fancl.co.jp | |
| Sponsor | |
| Institute | Medical Corporation Foundation Kenkoin Kenkoin Clinic |
| Institute | |
| Department | |
| Funding Source | |
| Organization | FANCL Corporation |
| Organization | |
| Division | |
| Category of Funding Organization | Profit organization |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000029317 |